Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,789,412
-
Total 13F shares
-
86,992,477
-
Share change
-
-3,915,512
-
Total reported value
-
$383,635,053
-
Put/Call ratio
-
274%
-
Price per share
-
$4.41
-
Number of holders
-
112
-
Value change
-
-$24,558,494
-
Number of buys
-
64
-
Number of sells
-
38
Institutional Holders of ACELYRIN, Inc. - Common Stock (SLRN) as of Q2 2024
As of 30 Jun 2024,
ACELYRIN, Inc. - Common Stock (SLRN) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,992,477 shares.
The largest 10 holders included
AyurMaya Capital Management Company, LP, CITADEL ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, MILLENNIUM MANAGEMENT LLC, ORBIMED ADVISORS LLC, venBio Partners LLC, T. Rowe Price Investment Management, Inc., and Blue Owl Capital Holdings LP.
This page lists
112
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.